Literature DB >> 8781121

Characterization of the mouse CD8 beta chain-encoding gene promoter region.

Y Kawachi1, F Otsuka, H Nakauchi.   

Abstract

We identified a regulatory region of the mouse CD8 beta chain-encoding gene (CD8b) promoter. The CD8b 5' upstream sequence could not drive the expression of the bacterial chloramphenicol acetyltransferase (CAT) gene without T-cell receptor or SV40 enhancer elements. The results of transient transfection assays indicated that the dominant transcription-activating element within the CD8b-promoter is located at -45 to -40 base pairs (CCGCCC) from the transcriptional initiation site. Elimination of this element, by deletion or specific point mutation, significantly reduced transcriptional activity from this promoter. The sequence of this core region corresponds to a GC box motif known to act as a binding site for a ubiquitously expressed transcriptional activator, Sp1. However, the promoter activity appeared to be T-cell-specific, and the gel retardation assay using the core sequence as a probe revealed formation of complexes with multiple nuclear factors, one of them being specific to T lineage cells. These data suggest that the CD8b promoter requires a cis-acting element as well as several nuclear factors for full-range, tissue-specific transcription.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781121     DOI: 10.1007/bf02602780

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  55 in total

1.  An improved method to make sequential deletion mutants for DNA sequencing.

Authors:  K Nakayama; H Nakauchi
Journal:  Trends Genet       Date:  1989-10       Impact factor: 11.639

2.  Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-2 genes.

Authors:  J Gabert; C Langlet; R Zamoyska; J R Parnes; A M Schmitt-Verhulst; B Malissen
Journal:  Cell       Date:  1987-08-14       Impact factor: 41.582

3.  CD8 is needed for development of cytotoxic T cells but not helper T cells.

Authors:  W P Fung-Leung; M W Schilham; A Rahemtulla; T M Kündig; M Vollenweider; J Potter; W van Ewijk; T W Mak
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

4.  DNase I sensitivity of the alpha 2(I) collagen gene: correlation with its expression but not with its methylation pattern.

Authors:  C McKeon; I Pastan; B de Crombrugghe
Journal:  Nucleic Acids Res       Date:  1984-04-25       Impact factor: 16.971

5.  An immunological role for the CD8 beta-chain.

Authors:  C J Wheeler; P von Hoegen; J R Parnes
Journal:  Nature       Date:  1992-05-21       Impact factor: 49.962

6.  Mouse Lyt-2 antigen: evidence for two heterodimers with a common subunit.

Authors:  G Jay; M A Palladino; G Khoury; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

7.  Specific expression of the human CD4 gene in mature CD4+ CD8- and immature CD4+ CD8+ T cells and in macrophages of transgenic mice.

Authors:  Z Hanna; C Simard; A Laperrière; P Jolicoeur
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

8.  The human Lyt-3 molecule requires CD8 for cell surface expression.

Authors:  J P DiSanto; R W Knowles; N Flomenberg
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

9.  CD8 beta chain influences CD8 alpha chain-associated Lck kinase activity.

Authors:  H Y Irie; K S Ravichandran; S J Burakoff
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

10.  A second subunit of CD8 is expressed in human T cells.

Authors:  A M Norment; D R Littman
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

View more
  1 in total

1.  cAMP-responsive element modulator α (CREMα) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease.

Authors:  Christian M Hedrich; Thomas Rauen; Jose C Crispin; Tomohiro Koga; Christina Ioannidis; Melissa Zajdel; Vasileios C Kyttaris; George C Tsokos
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.